Patent details

EP2846781 Title: PROLIPOSOMAL TESTOSTERONE FORMULATIONS

Basic Information

Publication number:
EP2846781
PCT Application Number:
US2013040325
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP137874384
PCT Publication Number:
WO2013170012
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PROLIPOSOMAL TESTOSTERONE FORMULATIONS
French Title of Invention:
FORMULATIONS DE TESTOSTÉRONE PROLIPOSOMALES
German Title of Invention:
PROLIPOSOMALE TESTOSTERONFORMULIERUNGEN
SPC Number:

Dates

Filing date:
09/05/2013
Grant date:
30/10/2019
EP Publication Date:
18/03/2015
PCT Publication Date:
14/11/2013
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
30/10/2019
EP B1 Publication Date:
30/10/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
09/05/2020
Expiration date:
09/05/2033
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
23/10/2019
 
 

Name:
Tesorx Pharma LLC
Address:
900 Willow Rd. Ste. B, Menlo Park, CA 94025, United States (US)

Name:
Western University Of Health Sciences
Address:
309 E. Second Street, Pomona, CA 91766, United States (US)

Inventor

1

Name:
THIRUCOTE, Ramachandran
Address:
United States (US)

2

Name:
BETAGERI, Guru, V.
Address:
United States (US)

3

Name:
KADAJJI, Veeran, Gowda
Address:
United States (US)

Priority

Priority Number:
201261644996 P
Priority Date:
09/05/2012
Priority Country:
United States (US)

Classification

IPC classification:
A61K 9/127; A61K 9/14; A61K 9/19; A61K 9/20; A61K 9/28; A61K 9/48; A61K 31/568;

Publication

European Patent Bulletin

Issue number:
201944
Publication date:
30/10/2019
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages